Microbot Operating Income from 2010 to 2025

MBOT Stock

USD 1.59 0.01 0.63%

Microbot Medical Operating Income yearly trend continues to be comparatively stable with very little volatility. Operating Income is likely to outpace its year average in 2025. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Microbot Medical generates from its operations. View All Fundamentals

Operating Income

First Reported

1991-03-31

Previous Quarter

-2.5 M

Current Value

-3.3 M

Quarterly Volatility

5.3 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Microbot Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbot Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 90.6 K, Interest Expense of 158.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 302, Dividend Yield of 58.41 or PTB Ratio of 5.21. Microbot financial statements analysis is a perfect complement when working with Microbot Medical Valuation or Volatility modules.

Check out the analysis of Microbot Medical Correlation against competitors.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Latest Microbot Medical's Operating Income Growth Pattern

Below is the plot of the Operating Income of Microbot Medical over the last few years. Operating Income is the amount of profit realized from Microbot Medical operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Microbot Medical is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Microbot Medical's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbot Medical's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Microbot Operating Income Regression Statistics

	Arithmetic Mean	(13,455,655)
	Geometric Mean	12,469,395
	Coefficient Of Variation	(93.43)
	Mean Deviation	9,829,585
	Median	(9,635,000)
	Standard Deviation	12,572,260
	Sample Variance	158.1T
	Range	44M
	R-Value	0.33
	Mean Square Error	151.2T
	R-Squared	0.11
	Significance	0.22
	Slope	863,658
	Total Sum of Squares	2370.9T

Microbot Operating Income History

	2025	-8.4 M
	2024	-8.9 M
	2023	-9.9 M
	2022	-13.3 M
	2021	-11.4 M
	2020	-9.1 M
	2019	-7.2 M

Other Fundumenentals of Microbot Medical

Non Operating Income Net Other

Microbot Medical Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Short Term Investments	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Property Plant Equipment	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.65	-0.75	-0.61	0.03	-0.24	0.7	0.98	0.58	0.36	0.01	-0.18	0.41	0.54	0.64	0.49	0.43	0.61	0.6	0.62	-0.35
Total Stockholder Equity	0.65		-0.93	0.16	-0.17	-0.25	-0.09	0.77	-0.07	-0.2	0.25	0.17	0.9	-0.19	-0.02	0.02	-0.05	0.14	0.88	0.88	0.01
Net Debt	-0.75	-0.93		-0.02	0.01	0.35	-0.11	-0.84	-0.15	0.01	-0.04	-0.18	-0.77	-0.04	-0.12	-0.11	-0.05	-0.27	-0.84	-0.85	0.21
Retained Earnings	-0.61	0.16	-0.02		-0.25	0.07	-0.96	-0.45	-0.68	-0.77	0.14	0.47	0.35	-0.79	-0.88	-0.67	-0.64	-0.64	0.1	0.06	0.42
Accounts Payable	0.03	-0.17	0.01	-0.25		0.07	0.19	-0.08	-0.07	0.58	0.05	0.06	-0.25	-0.01	0.31	0.33	0.22	0.33	-0.21	-0.2	-0.19
Net Receivables	-0.24	-0.25	0.35	0.07	0.07		-0.09	-0.25	-0.01	-0.23	0.01	-0.22	0.0	-0.08	-0.17	-0.22	-0.04	-0.12	-0.39	-0.42	0.72
Total Liab	0.7	-0.09	-0.11	-0.96	0.19	-0.09		0.55	0.83	0.67	-0.21	-0.39	-0.31	0.88	0.87	0.62	0.62	0.67	-0.05	-0.01	-0.46
Total Current Assets	0.98	0.77	-0.84	-0.45	-0.08	-0.25	0.55		0.5	0.2	0.02	-0.12	0.57	0.43	0.49	0.33	0.3	0.48	0.72	0.74	-0.25
Short Term Debt	0.58	-0.07	-0.15	-0.68	-0.07	-0.01	0.83	0.5		0.35	-0.33	-0.24	-0.26	0.92	0.64	0.27	0.38	0.54	-0.03	-0.01	-0.33
Common Stock	0.36	-0.2	0.01	-0.77	0.58	-0.23	0.67	0.2	0.35		-0.23	-0.27	-0.39	0.51	0.71	0.64	0.53	0.52	-0.08	-0.04	-0.5
Short Term Investments	0.01	0.25	-0.04	0.14	0.05	0.01	-0.21	0.02	-0.33	-0.23		0.58	0.07	-0.4	0.2	0.3	-0.04	0.4	-0.03	-0.02	-0.02
Current Deferred Revenue	-0.18	0.17	-0.18	0.47	0.06	-0.22	-0.39	-0.12	-0.24	-0.27	0.58		-0.01	-0.28	-0.01	0.12	-0.09	0.16	0.04	0.05	-0.21
Net Tangible Assets	0.41	0.9	-0.77	0.35	-0.25	0.0	-0.31	0.57	-0.26	-0.39	0.07	-0.01		-0.35	-0.34	-0.25	-0.18	-0.22	0.84	0.81	0.3
Long Term Debt Total	0.54	-0.19	-0.04	-0.79	-0.01	-0.08	0.88	0.43	0.92	0.51	-0.4	-0.28	-0.35		0.73	0.43	0.61	0.43	-0.05	-0.02	-0.38
Capital Surpluse	0.64	-0.02	-0.12	-0.88	0.31	-0.17	0.87	0.49	0.64	0.71	0.2	-0.01	-0.34	0.73		0.82	0.68	0.82	-0.04	0.0	-0.54
Deferred Long Term Liab	0.49	0.02	-0.11	-0.67	0.33	-0.22	0.62	0.33	0.27	0.64	0.3	0.12	-0.25	0.43	0.82		0.83	0.7	-0.07	-0.03	-0.55
Property Plant Equipment	0.43	-0.05	-0.05	-0.64	0.22	-0.04	0.62	0.3	0.38	0.53	-0.04	-0.09	-0.18	0.61	0.68	0.83		0.37	-0.06	-0.04	-0.3
Short Long Term Debt	0.61	0.14	-0.27	-0.64	0.33	-0.12	0.67	0.48	0.54	0.52	0.4	0.16	-0.22	0.43	0.82	0.7	0.37		-0.07	-0.03	-0.53
Net Invested Capital	0.6	0.88	-0.84	0.1	-0.21	-0.39	-0.05	0.72	-0.03	-0.08	-0.03	0.04	0.84	-0.05	-0.04	-0.07	-0.06	-0.07		1.0	-0.05
Net Working Capital	0.62	0.88	-0.85	0.06	-0.2	-0.42	-0.01	0.74	-0.01	-0.04	-0.02	0.05	0.81	-0.02	0.0	-0.03	-0.04	-0.03	1.0		-0.09
Capital Stock	-0.35	0.01	0.21	0.42	-0.19	0.72	-0.46	-0.25	-0.33	-0.5	-0.02	-0.21	0.3	-0.38	-0.54	-0.55	-0.3	-0.53	-0.05	-0.09

Click cells to compare fundamentals

About Microbot Medical Financial Statements

Microbot Medical shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although Microbot Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Microbot Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Microbot Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Operating Income	-8.9 M	-8.4 M
Non Operating Income Net Other	730.5 K	802.2 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Microbot Operating Income from 2010 to 2025

Latest Microbot Medical's Operating Income Growth Pattern

Microbot Operating Income Regression Statistics

Microbot Operating Income History

Other Fundumenentals of Microbot Medical

Microbot Medical Operating Income component correlations

About Microbot Medical Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Microbot Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY